Hologic Aktie News

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer and Hologic, Inc. (Nasdaq: HOLX) today announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The two companies will showcase the solution at the annual Society of Breast Imaging Symposium from April 11-14, 2024 in Montreal, Canada. Contrast-enhanced mammography is a sensitive and relatively l...

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #JNCCN--Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors .

The U.S. Food and Drug Administration on Tuesday warned patients and healthcare providers about the potential risk of serious complications arising from the use of Hologic's devices that are implanted in soft tissue.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #AI--Hologic to Unveil Groundbreaking AI Research at ECR 2024.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #NeedhamHealthcare--Hologic to Webcast Presentations at Upcoming Investor Conferences.

Hologic aims to elevate women's health globally, with diagnostics making up nearly half of sales. The company experienced a boom in COVID diagnostics sales in 2020 and 2021, creating headwinds thereafter, yet this is set to end in 2024. Amidst a gradual reduction in valuations and improved balance sheet strength, appeal is getting evident here.

Hologic, Inc. (HOLX) Q1 2024 Results - Earnings Call Transcript